GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $768,000 | +6.7% | 17,640 | +6.8% | 0.03% | +18.2% |
| Q1 2022 | $720,000 | -2.2% | 16,522 | -1.1% | 0.02% | -4.3% |
| Q4 2021 | $736,000 | +31.4% | 16,699 | +13.9% | 0.02% | +21.1% |
| Q3 2021 | $560,000 | +10.9% | 14,657 | +15.5% | 0.02% | -5.0% |
| Q2 2021 | $505,000 | +52.6% | 12,685 | +36.9% | 0.02% | +33.3% |
| Q1 2021 | $331,000 | +9.6% | 9,265 | +12.9% | 0.02% | +7.1% |
| Q4 2020 | $302,000 | -8.5% | 8,208 | -6.4% | 0.01% | -22.2% |
| Q3 2020 | $330,000 | -6.5% | 8,772 | +1.4% | 0.02% | -14.3% |
| Q2 2020 | $353,000 | +14.2% | 8,649 | +5.9% | 0.02% | -22.2% |
| Q1 2020 | $309,000 | -48.2% | 8,165 | -35.8% | 0.03% | -38.6% |
| Q4 2019 | $597,000 | +23.6% | 12,715 | +12.3% | 0.04% | +10.0% |
| Q3 2019 | $483,000 | +28.8% | 11,320 | +20.8% | 0.04% | +25.0% |
| Q2 2019 | $375,000 | -9.2% | 9,367 | -5.2% | 0.03% | -8.6% |
| Q1 2019 | $413,000 | +29.1% | 9,879 | +17.9% | 0.04% | +16.7% |
| Q4 2018 | $320,000 | -34.3% | 8,379 | -30.9% | 0.03% | -38.8% |
| Q3 2018 | $487,000 | +1.7% | 12,132 | +2.0% | 0.05% | -7.5% |
| Q2 2018 | $479,000 | +49.2% | 11,889 | +44.6% | 0.05% | +39.5% |
| Q1 2018 | $321,000 | +27.4% | 8,224 | +32.4% | 0.04% | +15.2% |
| Q3 2017 | $252,000 | -6.7% | 6,210 | -0.8% | 0.03% | -15.4% |
| Q2 2017 | $270,000 | -24.6% | 6,258 | -26.2% | 0.04% | -26.4% |
| Q1 2017 | $358,000 | +39.3% | 8,483 | +42.1% | 0.05% | +39.5% |
| Q3 2016 | $257,000 | +96.2% | 5,970 | +97.7% | 0.04% | +100.0% |
| Q2 2016 | $131,000 | +33.7% | 3,020 | +25.2% | 0.02% | +11.8% |
| Q1 2016 | $98,000 | +36.1% | 2,413 | +34.7% | 0.02% | +21.4% |
| Q4 2015 | $72,000 | +67.4% | 1,792 | +60.4% | 0.01% | +40.0% |
| Q3 2015 | $43,000 | -81.6% | 1,117 | -89.6% | 0.01% | -80.4% |
| Q2 2015 | $234,000 | -21.2% | 10,694 | -34.1% | 0.05% | -29.2% |
| Q1 2015 | $297,000 | +33.8% | 16,239 | +60.8% | 0.07% | +30.9% |
| Q4 2014 | $222,000 | +208.3% | 10,096 | +124.4% | 0.06% | +139.1% |
| Q3 2014 | $72,000 | +700.0% | 4,500 | +2531.6% | 0.02% | +666.7% |
| Q2 2014 | $9,000 | -73.5% | 171 | -73.2% | 0.00% | -75.0% |
| Q4 2013 | $34,000 | -51.4% | 638 | -54.4% | 0.01% | -60.0% |
| Q3 2013 | $70,000 | +3400.0% | 1,400 | +4142.4% | 0.03% | +2900.0% |
| Q2 2013 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |